Zacks Investment Research upgraded shares of STRAUMANN HLDG CHF0.10 (NASDAQ:SAUHF) from a hold rating to a strong-buy rating in a research note released on Wednesday morning. The brokerage currently has $797.00 price objective on the stock.
According to Zacks, “The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. “
Shares of STRAUMANN HLDG CHF0.10 (NASDAQ SAUHF) traded down $0.35 during mid-day trading on Wednesday, hitting $700.15. The stock had a trading volume of 4 shares, compared to its average volume of 31. STRAUMANN HLDG CHF0.10 has a 1-year low of $350.00 and a 1-year high of $704.00.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about STRAUMANN HLDG CHF0.10? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for STRAUMANN HLDG CHF0.10 and related companies.